Zobrazeno 1 - 10
of 2 025
pro vyhledávání: '"Jakubowiak, A."'
Autor:
Benjamin A. Derman, Ajay Major, Jennifer Cooperrider, Ken Jiang, Aubrianna Ramsland, Theodore Karrison, Tadeusz Kubicki, Andrzej J. Jakubowiak
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-7 (2024)
Abstract MRD2STOP is a pragmatic trial evaluating maintenance therapy cessation guided by measurable residual disease (MRD) negativity in multiple myeloma (MM). Eligible patients had previous MRD
Externí odkaz:
https://doaj.org/article/03712b7429334a0db4dd04bdc036fead
Autor:
Ajai Chari, Jonathan L. Kaufman, Jacob Laubach, Douglas W. Sborov, Brandi Reeves, Cesar Rodriguez, Rebecca Silbermann, Luciano J. Costa, Larry D. Anderson, Nitya Nathwani, Nina Shah, Naresh Bumma, Sarah A. Holstein, Caitlin Costello, Andrzej Jakubowiak, Tanya M. Wildes, Robert Z. Orlowski, Kenneth H. Shain, Andrew J. Cowan, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S. Lin, Peter M. Voorhees, Saad Z. Usmani, Paul G. Richardson
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract The randomized, phase 2 GRIFFIN study (NCT02874742) evaluated daratumumab plus lenalidomide/bortezomib/dexamethasone (D-RVd) in transplant-eligible newly diagnosed multiple myeloma (NDMM). We present final post hoc analyses (median follow-up
Externí odkaz:
https://doaj.org/article/bb6796db0ba84a22b84787f34a884f56
Autor:
Benjamin A. Derman, Jennifer Cooperrider, Jacalyn Rosenblatt, David E. Avigan, Murtuza Rampurwala, David Barnidge, Ajay Major, Theodore Karrison, Ken Jiang, Aubrianna Ramsland, Tadeusz Kubicki, Andrzej J. Jakubowiak
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract We evaluated the efficacy and safety of 24 cycles of Dara in combination with carfilzomib (K), lenalidomide (R), and dexamethasone (d) without autologous stem cell transplant (ASCT) in newly diagnosed multiple myeloma (NDMM) irrespective of
Externí odkaz:
https://doaj.org/article/83561b47ec1741d597e7e790e6a0d5db
Autor:
Natalie S. Callander, Rebecca Silbermann, Jonathan L. Kaufman, Kelly N. Godby, Jacob Laubach, Timothy M. Schmidt, Douglas W. Sborov, Eva Medvedova, Brandi Reeves, Binod Dhakal, Cesar Rodriguez, Saurabh Chhabra, Ajai Chari, Susan Bal, Larry D. Anderson, Bhagirathbhai R. Dholaria, Nitya Nathwani, Parameswaran Hari, Nina Shah, Naresh Bumma, Sarah A. Holstein, Caitlin Costello, Andrzej Jakubowiak, Tanya M. Wildes, Robert Z. Orlowski, Kenneth H. Shain, Andrew J. Cowan, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S. Lin, Smith Giri, Luciano J. Costa, Saad Z. Usmani, Paul G. Richardson, Peter M. Voorhees
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract In the MASTER study (NCT03224507), daratumumab+carfilzomib/lenalidomide/dexamethasone (D-KRd) demonstrated promising efficacy in transplant-eligible newly diagnosed multiple myeloma (NDMM). In GRIFFIN (NCT02874742), daratumumab+lenalidomide/
Externí odkaz:
https://doaj.org/article/ebc38d6b2c3c4c4a957f6410c2bc2f56
Autor:
Kubicki, Tadeusz, Dytfeld, Dominik, Barnidge, David, Sakrikar, Dhananjay, Przybyłowicz-Chalecka, Anna, Jamroziak, Krzysztof, Robak, Paweł, Czyż, Jarosław, Tyczyńska, Agata, Druzd-Sitek, Agnieszka, Giannopoulos, Krzysztof, Wróbel, Tomasz, Nowicki, Adam, Szczepaniak, Tomasz, Łojko-Dankowska, Anna, Matuszak, Magdalena, Gil, Lidia, Puła, Bartosz, Szukalski, Łukasz, Końska, Agnieszka, Zaucha, Jan Maciej, Walewski, Jan, Mikulski, Damian, Czabak, Olga, Robak, Tadeusz, Jiang, Ken, Cooperrider, Jennifer H., Jakubowiak, Andrzej J., Derman, Benjamin A.
Publikováno v:
In Blood 29 August 2024 144(9):955-963
Autor:
Yates, Samuel J., Cursio, John F., Artz, Andrew, Kordas, Keriann, Bishop, Michael R., Derman, Benjamin A., Kosuri, Satyajit, Riedell, Peter A., Kline, Justin, Jakubowiak, Andrzej, Mortel, Mylove, Johnson, Shalitha, Nawas, Mariam T.
Publikováno v:
In Blood Advances 23 July 2024 8(14):3785-3797
Autor:
Jakubowiak, Maciej, author
Publikováno v:
On the Fringes of Literature and Digital Media Culture: Perspectives from Eastern and Western Europe. 87:171-183
Autor:
Rojek, Alexandra E., Kline, Justin P., Feinberg, Nicholas, Appelbaum, Daniel E., Pu, Yonglin, Derman, Benjamin A., Jakubowiak, Andrzej, Kosuri, Satyajit, Liu, Hongtao, Nawas, Mariam T., Smith, Sonali M., Bishop, Michael R., Riedell, Peter A.
Publikováno v:
In Clinical Lymphoma, Myeloma and Leukemia February 2024 24(2):83-93
Autor:
Stephen Palmer, Yi Lin, Thomas G. Martin, Sundar Jagannath, Andrzej Jakubowiak, Saad Z. Usmani, Nasuh Buyukkaramikli, Hilary Phelps, Rafal Slowik, Feng Pan, Satish Valluri, Lida Pacaud, Graham Jackson
Publikováno v:
Oncology and Therapy, Vol 11, Iss 3, Pp 313-326 (2023)
Abstract Introduction Extrapolating long-term overall survival (OS) from shorter-term clinical trial data is key to health technology assessment in oncology. However, extrapolation using conventional methods is often subject to uncertainty. Using cil
Externí odkaz:
https://doaj.org/article/bf4c2994be6c42d0a5ac48bafa27bb4e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.